Coronary artery disease
Conditions
Interventions
Experimental group:Use intravascular shockwave therapy device coupled with SONICO-CX single-use coronary intravascular shockwave catheter
Sponsors
Zhongshan Hospital, Fudan University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: (1) Age >=18 years (2) Evidence of asymptomatic ischemia, stable or unstable angina pectoris (3) Calcified lesions requiring coronary intervention (4) Understand the purpose of the trial, participate voluntarily and be willing to accept clinical follow-up
Exclusion criteria
Exclusion criteria: (1) The patient refuses to undergo emergency CABG (2) Uncontrollable severe hypertension (systolic blood pressure >180 mm Hg or diastolic blood pressure >110 mm Hg) (3) Severe renal failure (serum creatinine >221 µmol/L). (4) Preoperative hemoglobin 1.7) (6) Hypercoagulable blood disorders (e.g., true erythrocytosis, platelet count >750×109/L, etc.) (7) History of stroke or TIA within 3 months (8) Patient's life expectancy is less than 12 months (9) Patient has an active systemic infection (10) The patient has a connective tissue disease (e.g., Marfonte's syndrome) (11) Patient is allergic to contrast material (12) Patients who have received a heart transplant (13) The patient is pregnant or breastfeeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The rate of operation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Instrument success rate;Death and Non-fatal myocardial infarction; | — |
Countries
China
Contacts
Public ContactShufu Chang
Zhongshan Hospital, Fudan University
Outcome results
None listed